155 BOVET RD., SUITE 303, SAN MATEO, CA
Investor Presentation
News, Letter Re Change in Certifying Accountant
News, Legal Opinion, Material Contracts
Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Material disclosure
Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner
Reports First Quarter 2025 Financial Results and Provides Corporate Updates
Changes in Board, Management or Compensation
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence